Advanced search    

Search: authors:"Qiu Yin Cai"

6 papers found.
Use AND, OR, NOT, +word, -word, "long phrase", (parentheses) to fine-tune your search.

Endostatin Polymorphism 4349G/A(D104N) Is Not Associated with Aggressiveness of Disease in Prostate Cancer

Disease Markers Endostatin polymorphism 4349G/A(D104N) is not associated with aggressiveness of disease in prostate cancer He Cheng Li Qiu Yin Cai Eric T. Shinohara Hui Cai Carolyn Cao Zuo Fei Wang

Endostatin Polymorphism 4349G/A(D104N) is not Associated with Aggressiveness of Disease in Postate Cancer

Endostatin is an important inhibitory molecule which mediates the sequential steps involved in angiogenesis. Lower level or impaired function of endostatin is associated with a higher risk of developing malignant solid tumors and with a worse prognosis of the disease. The endostatin N104 polymorphism might be associated with an impaired ability to inhibit angiogenesis. We...

Endostatin Polymorphism 4349G/A(D104N) Is Not Associated with Aggressiveness of Disease in Prostate Cancer

Disease Markers Endostatin polymorphism 4349G/A(D104N) is not associated with aggressiveness of disease in prostate cancer He Cheng Li Qiu Yin Cai Eric T. Shinohara Hui Cai Carolyn Cao Zuo Fei Wang

Endostatin Polymorphism 4349G/A(D104N) is not Associated with Aggressiveness of Disease in Postate Cancer

Endostatin is an important inhibitory molecule which mediates the sequential steps involved in angiogenesis. Lower level or impaired function of endostatin is associated with a higher risk of developing malignant solid tumors and with a worse prognosis of the disease. The endostatin N104 polymorphism might be associated with an impaired ability to inhibit angiogenesis. We...

Endostatin Polymorphism 4349G/A(D104N) Is Not Associated with Aggressiveness of Disease in Prostate Cancer

Disease Markers Endostatin polymorphism 4349G/A(D104N) is not associated with aggressiveness of disease in prostate cancer He Cheng Li Qiu Yin Cai Eric T. Shinohara Hui Cai Carolyn Cao Zuo Fei Wang

Endostatin Polymorphism 4349G/A(D104N) is not Associated with Aggressiveness of Disease in Postate Cancer

Endostatin is an important inhibitory molecule which mediates the sequential steps involved in angiogenesis. Lower level or impaired function of endostatin is associated with a higher risk of developing malignant solid tumors and with a worse prognosis of the disease. The endostatin N104 polymorphism might be associated with an impaired ability to inhibit angiogenesis. We...